Eupraxia Pharmaceuticals Inc. (EPRX)

CIK 1581178 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Eupraxia Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 20266-K0001171843-26-005913
Sep 2, 2026SUPPL0001193125-26-379038
Aug 24, 2026EFFECT9999999995-26-002742
Aug 19, 2026F-10/A0001193125-26-356803
Aug 13, 2026SCHEDULE 13G/A0000919574-26-005070
Aug 13, 20266-K0001171843-26-005479
Aug 11, 20266-K0001193125-26-345045
Aug 6, 2026F-X0001193125-26-336190
Aug 6, 2026F-100001193125-26-336139
Jul 15, 20266-K0001171843-26-004676
Jul 13, 20266-K0001171843-26-004605
Jul 7, 20266-K0001171843-26-004516
Jun 22, 20266-K0001171843-26-004213
May 29, 20266-K0001171843-26-003787
May 29, 20266-K0001171843-26-003785
May 28, 20266-K0001171843-26-003762
May 12, 20266-K0001193125-26-219802
May 12, 2026SCHEDULE 13G/A0000919574-26-002903
May 6, 20266-K0001171843-26-003051
May 5, 20266-K0001171843-26-003003
May 1, 20266-K0001171843-26-002939
Apr 22, 20266-K0001171843-26-002633
Apr 21, 20266-K0001171843-26-002597
Apr 15, 20266-K0001193125-26-155275
Apr 15, 20266-K0001171843-26-002448